Literature DB >> 33651598

Kinetic Resolution of Allyltriflamides through a Pd-Catalyzed C-H Functionalization with Allenes: Asymmetric Assembly of Tetrahydropyridines.

José Manuel González1, Borja Cendón1, José Luis Mascareñas1, Moisés Gulías1.   

Abstract

Enantioenriched, six-membered azacycles are essential structural motifs in many products of pharmaceutical or agrochemical interest. Here we report a simple and practical method for enantioselective assembly of tetrahydropyridines, which is paired to a kinetic resolution of α-branched allyltriflamides. The reaction consists of a formal (4+2) cycloaddition between the allylamine derivatives and allenes and is initiated by a palladium(II)-catalyzed C-H activation process. Both the chiral allylamide precursors and the tetrahydropyridine adducts were successfully obtained in high yields, with excellent enantioselectivity (up to 99% ee) and selectivity values of up to 127.

Entities:  

Year:  2021        PMID: 33651598     DOI: 10.1021/jacs.1c01929

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  3 in total

1.  Mapping Ambiphile Reactivity Trends in the Anti-(Hetero)annulation of Non-Conjugated Alkenes via PdII /PdIV Catalysis.

Authors:  Hui-Qi Ni; Phillippa Cooper; Shouliang Yang; Fen Wang; Neal Sach; Pranali G Bedekar; Joyann S Donaldson; Michelle Tran-Dubé; Indrawan J McAlpine; Keary M Engle
Journal:  Angew Chem Int Ed Engl       Date:  2022-02-02       Impact factor: 15.336

2.  Recent advances in palladium-catalyzed (hetero)annulation of C[double bond, length as m-dash]C bonds with ambiphilic organo(pseudo)halides.

Authors:  Hui-Qi Ni; Phillippa Cooper; Keary M Engle
Journal:  Chem Commun (Camb)       Date:  2021-08-03       Impact factor: 6.065

Review 3.  Transition-Metal-Catalyzed Annulations Involving the Activation of C(sp3 )-H Bonds.

Authors:  Marc Font; Moisés Gulías; José Luis Mascareñas
Journal:  Angew Chem Int Ed Engl       Date:  2021-12-02       Impact factor: 16.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.